Breaking Deadly Airstrike in Southern Lebanon Kills Seven Amid Withdrawal Agreement Yamamoto Shines as Dodgers Defeat Brewers 3-1 Settler Violence Disrupts Palestinian Lives in West Bank Amidst Political Tensions DNC Proposes 2028 Primary Calendar Emphasizing Diverse Electorates Owen Ansah Claims European 200m Gold Amidst Doping Test Allegations

Saturday August 15, 2026

Reporter

Belite Bio, Inc

3Articles Published

4Communities Covered

Published Articles

Press Release

Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update

Aug 12

Press Release

Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1

Aug 11

Press Release

Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results

Aug 6